Neurological Disorder Diagnostics Market: By Component, By Technology, By Disease Type, By End User, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Neurological Disorder Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Component (Instruments, Reagents, and Kits, Software, and Services), By Technology (Immunoassay, PCR Techniques), By Disease Type (Alzheimers disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Others), By End User (Hospitals and Clinics, Diagnostic Centers, Academic, and Research Institutes), and Region Forecast 2020-2031

Report ID:35761

Published Date:Apr 2023

No of Pages:200

Format:

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Neurological Disorder Diagnostics Market size was valued at US$ 17,195.5 million in 2024 and is expected to reach US$ 21,730.0 million by 2031, growing at a significant CAGR of 3.4% from 2025-2031.

summary download arrow Download Sample

Global Neurological Disorder Diagnostics Market Summary

Study Period

2023-2029

Base Year

2024

CAGR

3.4%

Largest Market

N/A

Fastest Growing Market

N/A

Global Neurological Disorder Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2023-2029

Market Size in 2024

US$ 17,195.5 million

Market Size in 2031

US$ 21,730.0 million

Market CAGR

3.4%

By Component

  • Instruments
  • Reagents
  • Kits
  • Software
  • Services

By Technology

  • Immunoassay
  • PCR Techniques

By Disease Type

  • Alzheimer's Sisease
  • Dementia
  • Parkinson's Disease
  • Epilepsy
  • Traumatic Brain Injury
  • Others

By End User

  • Hospitals
  • Clinics, Diagnostic Centers
  • Academic
  • Research Institutes

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The neurological disorder diagnostics market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The neurological disorder diagnostics market size was valued at US$ 17,195.5 million in 2024 and is expected to reach US$ 21,730.0 million by 2031, growing at a significant CAGR of 3.4% from 2025-2031.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Content Updated Date: Oct 2025

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Neurological Disorder Diagnostics Market Introduction
2.1. Global Neurological Disorder Diagnostics Market Taxonomy
2.2. Global Neurological Disorder Diagnostics Market Definitions
2.2.1. By Component
2.2.2. By Technology
2.2.3. By Disease Type
2.2.4. By End User
2.2.5. By Region
3. Global Neurological Disorder Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Neurological Disorder Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Neurological Disorder Diagnostics Market Competition Landscape
3.7. Epidemiology
4. Global Neurological Disorder Diagnostics Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Neurological Disorder Diagnostics Market, By Component, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents and Kits
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Neurological Disorder Diagnostics Market, By Technology, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.1. Immunoassay
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. PCR Techniques
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Neurological Disorder Diagnostics Market, By Disease Type, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.1. Alzheimers Disease
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dementia
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Parkinson's Disease
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Epilepsy
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Traumatic Brain Injury
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Neurological Disorder Diagnostics Market, By End User, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.1. Hospitals and Clinics
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Diagnostic Centers
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Research Institutes
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Technology, By Disease Type, By End User, and Region, 2024 - 2030
10. North America Neurological Disorder Diagnostics Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
10.1. Component Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.2. Reagents and Kits
10.1.3. Software and Services
10.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Immunoassay
10.2.2. PCR Techniques
10.3. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Alzheimers Disease
10.3.2. Dementia
10.3.3. Parkinson's Disease
10.3.4. Epilepsy
10.3.5. Traumatic Brain Injury
10.3.6. Others
10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals and Clinics
10.4.2. Diagnostic Centers
10.4.3. Academic and Research Institutes
10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2024 - 2030
10.7. North America Neurological Disorder Diagnostics Market Dynamics Trends
11. Europe Neurological Disorder Diagnostics Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
11.1. Component Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.2. Reagents and Kits
11.1.3. Software and Services
11.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Immunoassay
11.2.2. PCR Techniques
11.3. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Alzheimers Disease
11.3.2. Dementia
11.3.3. Parkinson's Disease
11.3.4. Epilepsy
11.3.5. Traumatic Brain Injury
11.3.6. Others
11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals and Clinics
11.4.2. Diagnostic Centers
11.4.3. Academic and Research Institutes
11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2024 - 2030
11.7. Europe Neurological Disorder Diagnostics Market Dynamics Trends
12. Asia-Pacific Neurological Disorder Diagnostics Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
12.1. Component Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.2. Reagents and Kits
12.1.3. Software and Services
12.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Immunoassay
12.2.2. PCR Techniques
12.3. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Alzheimers Disease
12.3.2. Dementia
12.3.3. Parkinson's Disease
12.3.4. Epilepsy
12.3.5. Traumatic Brain Injury
12.3.6. Others
12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals and Clinics
12.4.2. Diagnostic Centers
12.4.3. Academic and Research Institutes
12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, by Disease Type, By End User, and Country, 2024 - 2030
12.7. Asia-Pacific Neurological Disorder Diagnostics Market Dynamics Trends
13. Latin America Neurological Disorder Diagnostics Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
13.1. Component Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.2. Reagents and Kits
13.1.3. Software and Services
13.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Immunoassay
13.2.2. PCR Techniques
13.3. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Alzheimers Disease
13.3.2. Dementia
13.3.3. Parkinson's Disease
13.3.4. Epilepsy
13.3.5. Traumatic Brain Injury
13.3.6. Others
13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals and Clinics
13.4.2. Diagnostic Centers
13.4.3. Academic and Research Institutes
13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2024 - 2030
13.7. Latin America Neurological Disorder Diagnostics Market Dynamics Trends
14. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
14.1. Component Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.2. Reagents and Kits
14.1.3. Software and Services
14.2. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Immunoassay
14.2.2. PCR Techniques
14.3. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Alzheimers Disease
14.3.2. Dementia
14.3.3. Parkinson's Disease
14.3.4. Epilepsy
14.3.5. Traumatic Brain Injury
14.3.6. Others
14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals and Clinics
14.4.2. Diagnostic Centers
14.4.3. Academic and Research Institutes
14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoEnd User Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Component, By Capacity, By Disease Type, By End User, and Country, 2024 - 2030
14.7. MEA Neurological Disorder Diagnostics Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis)
15.2.1. F. Hoffmann La Roche Ltd.
15.2.2. Creative Biolabs
15.2.3. Diadem Srl
15.2.4. Fujirebio Diagnostics
15.2.5. Quest Diagnostics
15.2.6. Thermo Fisher Scientific, Inc.
15.2.7. Bio-Rad Laboratories, Inc.
15.2.8. Siemens Healthineers
16. Research Methodology
17. Appendix and Abbreviations

Key Market Players

  • Hoffmann La Roche Ltd.
  • Creative Biolabs
  • Diadem Srl
  • Fujirebio Diagnostics
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers

Related Industry Reports

Attention Deficit Hyperactivity Disorder Market

CDKL5 Deficiency Disorder Treatment Market

Global Neurological Biomarkers Market

Global Non Dystrophic Myotonia Disorder Treatment Market